16 March 2022
Impact Healthcare REIT plc
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
PDMR Notification
The Company announces that Chris Santer, Non-Executive Director of the Company and a person discharging managerial responsibilities in the Company ("PDMR"), on 21 February 2022, was allotted 1,570 ordinary shares at a price of 114 pence per share. This allotment took place under the Company's Open Offer, Initial Placing, Offer for Subscription and Intermediaries Offer announced on 27 January 2022.
In total Chris Santer will be interested in 14,137 Ordinary Shares, representing approximately 0.0037% per cent of the Company's issued Ordinary Share capital.
PDMR Notification Form:
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further details:
| 1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA") | |||||
| a) | Name | Christopher John Santer | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | PDMR | ||||
| b) | Initial notification/amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Impact Healthcare REIT PLC | ||||
| b) | LEI | 213800AX3FHPMJL4IJ53 | ||||
| 4. | Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1 pence each | ||||
| Identification code | GB00BYXVMJ03 | |||||
| b) | Nature of the Transaction | Acquisition of Shares | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information | 1,570 ordinary shares in aggregate | ||||
| e) | Date of the transaction | 21 February 2022 | ||||
| f) | Place of the transaction | London Stock Exchange | ||||
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
ENDS
| JTC (UK) Limited - Company Secretary Christopher Gibbons |
+44 (0) 203 846 9774 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
